Reach Us +44-1647-403003
Immunoglobulin D Multiple Myeloma-A Rare Case | OMICS International | Abstract
ISSN: 2165-7920

Journal of Clinical Case Reports
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Immunoglobulin D Multiple Myeloma-A Rare Case

Sebnem Izmir Guner1*, Didem Karacetin2 and Ekrem Guner3
1Department of Hematology, Istanbul Kemerburgaz University, Medicalpark Bahçelievler Hospital, Istanbul, Turkey
2Department of Radiation Oncology, Istanbul Research and Training Hospital, Istanbul, Turkey
3Department of Urology, Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey
Corresponding Author : Sebnem Izmir Guner
Department of Hematology
Istanbul Kemerburgaz University
Medicalpark Bahcelievler Hospital
Istanbul, Turkey
Tel: 00905326148498
E-mail: [email protected]
Received September 02, 2015; Accepted October 09, 2015; Published October 16, 2015
Citation: Guner S, Karacetin D, Guner E (2015) Immunoglobulın D Multiple Myeloma-A Rare Case. J Clin Case Rep 5:618. doi:10.4172/2165-7920.1000618
Copyright: © 2015 Guner S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at Pubmed, Scholar Google


Introduction Immunoglobulin D multiple myeloma (IgD MM) accounts for almost 2% of all myeloma cases and has usually an poor prognosis. Due to its rarity, the reports on this disorder in the literature are limited. Case Report We therefore present a case of Ig D multiple myeloma. The age of the patients was 56 years old and the common presenting symptoms were anorexia, weight loss and bone pain. The patient was also presented with neurological symptoms (peripherial neuropaty), renal impairment and kappa paraproteinemia. Conclusion The small group of patients who have IgD multiple myeloma is rare and considered to have a poor prognosis compared to other MM isotypes. The clinical features and prognosis of patients with IgD MM are not the same from those that characterize patients with other immunoglobulin MM subtypes. New treatment strategies that aim to induce high-quality responses before ASCT and after ASCT may be needed to improve the outcomes of such patients.